Persistent synthesis of IFN-β has been shown to impair anti-inflammatory IL-10 signaling in NOD mice [109] and heightened IFN-α/β expression has been associated with T1D development in both mice and humans [110,111]. Here, IFNA1 is linked to type 1 diabetes mellitus.